JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2008; 51:920-929, doi:10.1016/j.jacc.2007.09.069
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Google Scholar
Right arrow Articles by Schwartz, P. J.
Right arrow Articles by Brink, P. A.
PubMed
Right arrow Articles by Schwartz, P. J.
Right arrow Articles by Brink, P. A.

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome

Peter J. Schwartz, MD, FACC*,{dagger},{ddagger},||,**,{dagger}{dagger},*, Emilio Vanoli, MD*, Lia Crotti, MD, PhD*,{dagger},{ddagger}, Carla Spazzolini, DVM*, Chiara Ferrandi, BSc{ddagger}, Althea Goosen, BSc**, Paula Hedley, MSc{ddagger}{ddagger}, Marshall Heradien, MD**, Sara Bacchini, MD*,{dagger}, Annalisa Turco, MD*,{dagger}, Maria Teresa La Rovere, MD#, Antonella Bartoli, PharmD§, Alfred L. George, Jr, MD§§ and Paul A. Brink, MD**

* Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy
{dagger} Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
{ddagger} Molecular Cardiology Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
§ Clinical Pharmacokinetics Laboratory, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy
|| Laboratory of Cardiovascular Genetics, IRCCS Istituto Auxologico, Milan, Italy
Department of Cardiology, Policlinico di Monza, Monza, Italy
# Centro Medico di Montescano, IRCCS Fondazione "Salvatore Maugeri," Montescano, Italy
** Department of Medicine, University of Stellenbosch, Stellenbosch, South Africa
{dagger}{dagger} Cardiovascular Genetics Laboratory, Hatter Institute for Cardiovascular Research, Department of Medicine, University of Cape Town, Cape Town, South Africa
{ddagger}{ddagger} US/MRC Centre for Molecular and Cellular Biology, University of Stellenbosch, Stellenbosch, South Africa
§§ Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee.

Manuscript received June 6, 2007; revised manuscript received August 31, 2007, accepted September 20, 2007.

* Reprint requests and correspondence: Dr. Peter J. Schwartz, Professor and Chairman, Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo, Viale Golgi 19 - 27100 Pavia, Italy. (Email: pjqt{at}compuserve.com).

Objectives: The purpose of this study was to test the hypothesis that differences in autonomic responses might modify clinical severity in long QT syndrome type 1 (LQT1) patients, those with KCNQ1 mutations and reduced IKs, in whom the main arrhythmia trigger is sympathetic activation.

Background: Some long QT syndrome (LQTS) patients experience life-threatening cardiac arrhythmias, whereas others remain asymptomatic throughout life. This clinical heterogeneity is currently unexplained.

Methods: In a South African LQT1 founder population segregating KCNQ1-A341V, we correlated major cardiac events to resting heart rate (HR) and to baroreflex sensitivity (BRS) on and off beta-adrenergic blockers (BB).

Results: In 56 mutation carriers (MCs), mean HR was lower among asymptomatic patients (p < 0.05). Among MCs with a QT interval corrected for heart rate ≤500 ms, those in the lower HR tertile were less likely to have suffered prior cardiac events (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.04 to 0.79, p < 0.02). The BRS was lower among asymptomatic than symptomatic MCs (11.8 ± 3.5 ms/mm Hg vs. 20.1 ± 10.9 ms/mm Hg, p < 0.05). A BRS in the lower tertile was associated with a lower probability of being symptomatic (OR 0.13, 95% CI 0.02 to 0.96, p < 0.05). A similar trend was observed during BB. The MCs in the lower tertile for both HR and BRS were less frequently symptomatic than MCs with different patterns (20% vs. 76%, p < 0.05). Subjects with either ADRA2C-Del322-325 or homozygous for ADRB1-R389, 2 polymorphisms predicting enhanced adrenergic response, were more likely to have BRS values above the upper tertile (45% vs. 8%, p < 0.05).

Conclusions: Lower resting HR and "relatively low" BRS are protective factors in KCNQ1-A341V carriers. A plausible underlying mechanism is that blunted autonomic responses prevent rapid HR changes, arrhythmogenic when IKs is reduced. These findings help understanding phenotypic heterogeneity in LQTS and identify a physiological risk modifier, which is probably genetically determined.

Abbreviations and Acronyms
  BB = beta-adrenergic blockers
  BRS = baroreflex sensitivity
  CI = confidence interval
  ECG = electrocardiogram
  HR = heart rate
  IKs = delayed rectifier potassium current (slow)
  LQT1 = long QT syndrome type 1
  LQTS = long QT syndrome
  MC = mutation carrier
  OR = odds ratio


Related articles in JACC:

The Congenital Long QT Syndrome: A Mask for Many Faces
Ralph Lazzara
JACC 2008 51: 930-932. [Full Text]  

Inside This Issue of JACC

JACC 2008 51: A31-A32. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. Lazzara
The congenital long QT syndrome: a mask for many faces.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 930 - 932.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2008 by the American College of Cardiology Foundation.